India  
 
NewsR.in

Sensex plunges 562 points on COVID concerns, ONGC top loser

Video Credit: ANI - Duration: 01:08s - Published
Sensex plunges 562 points on COVID concerns, ONGC top loser

Sensex plunges 562 points on COVID concerns, ONGC top loser

Equity benchmark indices closed lower after a volatile trading session on Wednesday as investors weighed the impact of rising Covid-19 cases amid mixed global cues.

Expanded lockdowns in certain states due to rising infections remained a concern for the market while the Prime Minister asked chief ministers to take decisive steps quickly to stop the emergence of second wave.

At the closing bell, the BSE SandP Sensex was down by 562 points or 1.12 per cent at 49,802 while the Nifty 50 slipped by 189 points or 1.27 per cent to 14,721.

All sectoral indices at the National Stock Exchange were in the negative terrain with Nifty PSU bank dipping by 3.7 per cent, realty by 2.9 per cent, auto and pharma by 1.8 per cent each.

Among stocks, ONGC cracked by 4.8 per cent to close at Rs 109.50 per share while Bharat Petroleum Corporation was also down by 4.8 per cent to Rs 109.50 per share.


You Might Like


๐Ÿ’ก newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Contagious disease caused by SARS-CoV-2

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis [Video]

Cure or Threat? Wuhan Lab's New Intranasal Vaccine Sparks Fears of Another Covid-like Crisis

A new intranasal vaccine developed by researchers at the Wuhan lab has recently been unveiled, promising a novel approach to combating infectious diseases. However, this breakthrough has also sparked significant controversy and concern. While the vaccineโ€™s potential to offer a more accessible and efficient method of vaccination is hailed as a major advancement, its origins and the circumstances surrounding its development are raising alarms about a possible new health crisis. Critics worry that the technology used in this vaccine could inadvertently lead to another pandemic-like scenario if not carefully monitored. As the world cautiously watches, the vaccine's rollout is stirring a heated debate about safety, preparedness, and the ethical implications of such advanced biological research. #IntranasalVaccine #WuhanLab #CovidCrisis #HealthFears #VaccineDebate #PandemicRisk #BioResearch #VaccineDevelopment #PublicHealth #InfectiousDiseases #SafetyConcerns #GlobalHealth #VaccineInnovation #EthicalIssues #HealthSecurity ~HT.97~PR.152~

Credit: Oneindia    Duration: 03:29Published

Related videos from verified sources

Equity gauges dip, HDFC Bank top loser [Video]

Equity gauges dip, HDFC Bank top loser

Equity benchmark indices dipped by over half a per cent during early hours on Wednesday amid mixed global cues with banking and financial stocks taking a hit. At 10:15 am, the BSE SandP Sensex was down..

Credit: ANI     Duration: 01:19Published
Sensex jumps 568 points, Tata shares rally after SC verdict [Video]

Sensex jumps 568 points, Tata shares rally after SC verdict

Equity benchmark indices closed over 1 per cent higher on Friday on the back of favourable global cues amid progress in distribution of Covid-19 vaccines. At the closing bell, the BSE S-P Sensex was up..

Credit: ANI     Duration: 01:30Published
Equity indices trade higher, autos in focus [Video]

Equity indices trade higher, autos in focus

Equity benchmark indices traded higher during early hours on Friday on the back of favourable global cues amid progress in the distribution of Covid-19 vaccines. At 10:15 am, the BSE S-P Sensex was up..

Credit: ANI     Duration: 01:21Published